Cargando…

MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis

BACKGROUND: Excessive and inappropriate immune responses are the hallmark of several autoimmune disorders, including the inflammatory bowel diseases (IBD): Crohn’s disease (CD) and ulcerative colitis (UC). A complex etiology involving both environmental and genetic factors influences IBD pathogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaefer, Jeremy S, Attumi, Taraq, Opekun, Antone R, Abraham, Bincy, Hou, Jason, Shelby, Harold, Graham, David Y, Streckfus, Charles, Klein, John R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335694/ https://www.ncbi.nlm.nih.gov/pubmed/25886994 http://dx.doi.org/10.1186/s12865-015-0069-0

Ejemplares similares

Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders
por: Opekun, Antone R., et al.
Publicado: (2016)

Plasma microRNA Profile Differentiates Crohn’s Colitis From Ulcerative Colitis
por: Netz, Uri, et al.
Publicado: (2018)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis
por: Harris, R Alan, et al.
Publicado: (2014)

Crohn's disease and ulcerative colitis Surgical management
por: Wilkinson, A J
Publicado: (1996)

The safety of vedolizumab for ulcerative colitis and Crohn's disease
por: Colombel, Jean-Frédéric, et al.
Publicado: (2017)

Ulcerative Colitis and Crohn's Disease: Similarities and Distinctions
por: Sawyerr, Af M, et al.
Publicado: (1994)

Review of pregnancy in Crohn’s disease and ulcerative colitis
por: Laube, Robyn, et al.
Publicado: (2021)

Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures
por: Shome, Mahasish, et al.
Publicado: (2022)

Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis
por: Abraham, Bincy P, et al.
Publicado: (2022)

Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis
por: Chan, Simon S. M., et al.
Publicado: (2014)

Crohn’s Disease and Ulcerative Colitis Show Unique Cytokine Profiles
por: Nemeth, Zoltan H, et al.
Publicado: (2017)

Expressing the Differences between Crohn Disease and Ulcerative Colitis
por: Wijmenga, Cisca
Publicado: (2005)

The Changing Prognosis of Ulcerative Colitis and Crohn Disease by Decades
por: Korelitz, Burton I, et al.
Publicado: (2021)

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
por: Kang, Da-Yeon, et al.
Publicado: (2023)

Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
por: Irani, Malcolm, et al.
Publicado: (2023)

CORRIGENDUM: Dissecting the cell to nucleus, perinucleus and cytosol
por: Shaiken, Tattym E., et al.
Publicado: (2014)

Dissecting the cell to nucleus, perinucleus and cytosol
por: Shaiken, Tattym E., et al.
Publicado: (2014)

Author Correction: Dissecting the cell to nucleus, perinucleus and cytosol
por: Shaiken, Tattym E., et al.
Publicado: (2021)

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
por: Rosario, M., et al.
Publicado: (2015)

Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis
por: Clerc, Florent, et al.
Publicado: (2023)

Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?
por: Gilroy, Leah, et al.
Publicado: (2014)

Gastritis Associated with Initially Pediatric Crohn's Disease and Ulcerative Colitis
por: Basturk, Ahmet, et al.
Publicado: (2018)

Tofacitinib, two-faced Janus in ulcerative colitis and Crohn’s disease?
por: Biemans, Vince BC, et al.
Publicado: (2020)

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis
por: Dulai, Parambir S., et al.
Publicado: (2020)

Salivary Stress/Immunological Markers in Crohn’s Disease and Ulcerative Colitis
por: Finamore, Alberto, et al.
Publicado: (2020)

A comparison of diverticulitis in Crohn's disease versus ulcerative colitis
por: Persaud, Alana, et al.
Publicado: (2019)

Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
por: Sankarasubramanian, Jagadesan, et al.
Publicado: (2020)

Prevalence of endodontic infection in patients with Crohn´s disease and ulcerative colitis
por: Poyato-Borrego, Manuel, et al.
Publicado: (2021)

Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease
por: Yarani, Reza, et al.
Publicado: (2022)

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
por: Biemans, Vince B. C., et al.
Publicado: (2020)

MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2021)

The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study
por: Malaty, Hoda M, et al.
Publicado: (2013)

Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis
por: de Souza, Helton Luis, et al.
Publicado: (2012)

Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
por: Dharmasiri, Suranga, et al.
Publicado: (2021)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
por: Lee, Heung Bum, et al.
Publicado: (1997)

Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab
por: Petkau, Jill MV, et al.
Publicado: (2016)

Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis
por: Dobre, Maria, et al.
Publicado: (2018)

Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis
por: Del Hoyo, Javier, et al.
Publicado: (2019)

Potential Salivary Markers for Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis
por: Nijakowski, Kacper, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4p4jj7ihcq3kvmhd0n7idco46s